LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (“ScienTech”) filed its monthly return for the period ended 31 July 2026, confirming that registered share capital and the number of issued H-shares remained unchanged during the month. Registered capital stood at RMB 346.75 million, represented by 346.75 million ordinary H-shares with a par value of RMB 1.00 each. No new shares were issued, cancelled or converted, and the company continued to hold zero treasury shares.

Although July saw no on-market activity, 1.32 million H-shares that were repurchased on 22 May 2026 are still pending formal cancellation. The buy-backs were executed at prices ranging from HKD 10.17 to HKD 11.41 per share. Once cancelled, the outstanding share count will be reduced accordingly; until then, the repurchased shares remain part of the issued share capital.

ScienTech confirmed compliance with the Main Board public-float requirement, maintaining at least the 15 % minimum public float prescribed at the time of listing. All share-related actions referenced in the filing were duly authorised by the board and executed in line with Hong Kong listing rules and relevant regulatory requirements.